So, my understanding of the lay of the land is that Bot will await positive phase 2b Australian results next month, and then if positive apply for IND in the USA, and at some point release their clinical trial plan for the USA.
The FDA then has 30 days to approve the IND- probably Jan 2021.
Bot then commences the clinical trials it is planning in the USA 2021, and applies for fast track status
So, my understanding of the lay of the land is that Bot will...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.5¢ | $1.324M | 3.541M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4056 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 653729 | 17 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |